Yaoming Shengji is a CTDMO under WuXi AppTec that focuses on cell and gene therapy, committed to accelerating and revolutionizing the development, testing, manufacturing, and commercialization of cell therapy, gene therapy, and other high-end therapies. Yaoming Shengji can help global customers push more innovative therapies to the market as soon as possible, benefiting patients. Shanghai Yaoming Shengji Pharmaceutical Technology Co., Ltd. was established on September 14, 2020, with its enterprise address located at Building 40, No. 356 Zhengbo Road, Lingang New Area, China (Shanghai) Pilot Free Trade Zone. The industry it belongs to is technology promotion and application services, and its business scope includes general projects such as technical services, technology development, technology consulting, technology exchange, technology transfer, and technology promotion; Enterprise management; Information consulting services (excluding licensed information consulting services); Health consultation services (excluding diagnosis and treatment services); Technology import and export; Import and export of goods. (Except for projects that require approval according to law, business activities can be carried out independently based on the business license in accordance with the law) Licensed project: commissioned production of drugs. (Projects that require approval according to law can only be carried out after being approved by relevant departments. The specific business projects shall be subject to the approval documents or licenses issued by relevant departments.). The current operating status of Shanghai Yaoming Shengji Pharmaceutical Technology Co., Ltd. is in existence (in operation, open, registered).
Odor components | Odor inlet indicators | Odor discharge indicators | Exhaust pipe height |
H2S | ≤100mg/m3 | ≤0.6kg/h | 15m |
NH3 | ≤40mg/m3 | ≤0.6kg/h | |
C2H6S | ≤50mg/m3 | ≤0.6kg/h | |
Odour | ≤3000 | ≤800 |